Medicus Pharma (MDCX) vs MIRA Pharmaceuticals (MIRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
MIRA Pharmaceuticals (MIRA) has outperformed Medicus Pharma (MDCX) over the past year, losing 44.4% versus a loss of 96.3%. MIRA Pharmaceuticals is the larger company by market cap ($31.3 million vs $138,068), about 226.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MDCX | MIRA |
|---|---|---|
| Share price | $0.0921 | $0.7455 |
| Market cap | $138.07K | $31.33M |
| 1-day change | -9.62% | +6.05% |
| YTD return | -93.98% | -50.63% |
| 1-year return | -96.33% | -44.37% |
| EPS (TTM) | $-119.00 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $139.00 | $2.45 |
| 52-week low | $0.084 | $0.60 |
| Distance from 52-week high | -99.93% | -69.57% |
| Analyst consensus | none | none |
| Avg. price target upside | +4785.99% | +369.48% |
| Average volume | 92.96K | 585.75K |
| Shares outstanding | 1.50M | 42.02M |
| Employees | 16 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MIRA Pharmaceuticals is about 226.9 times larger than Medicus Pharma by market value ($31.33M vs $138.07K).
- MIRA has outperformed MDCX by 52.0 percentage points over the past year.
About Medicus Pharma
MDCX stock →Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin.
Health Care · Biotechnology: Pharmaceutical Preparations · 16 employees
About MIRA Pharmaceuticals
MIRA stock →MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.
Health Care · Biotechnology: Pharmaceutical Preparations
MDCX vs MIRA FAQ
Which is bigger, Medicus Pharma or MIRA Pharmaceuticals?
MIRA Pharmaceuticals (MIRA) is larger, with a market capitalization of $31.33M compared with $138.07K for Medicus Pharma (MDCX).
Which stock has performed better over the past year, MDCX or MIRA?
MIRA returned -44.37% over the past 12 months, compared with -96.33% for MDCX (price return, excluding dividends). Past performance does not predict future results.
Are Medicus Pharma and MIRA Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.